Brand Description: Turning Point Therapeutics is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to patients suffering from serious diseases. As a subsidiary of Bristol Myers Squibb, we are committed to transforming lives through science. Our mission is to explore the uncharted terrain of the human body, seeking to understand how to cure diseases and improve the quality of life for patients worldwide.

With a focus on precision oncology, we are developing targeted therapies that address the unique molecular drivers of cancer. Our team of dedicated scientists, researchers, and healthcare professionals are driven by curiosity and a passion for making a difference. From discovery to clinical trials, we strive to bring new treatment options to patients in need.

At Turning Point Therapeutics, we are using science to redefine what is possible in healthcare